Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Gold IRA Companies
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Gold IRA Review
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
ASND
Stock Latest News
Company Announcements
Ascendis Pharma Expands Yorvipath Into Adolescents, Raising Long-Term Growth Hopes
4d ago
ASND
Premium
The Fly
Ascendis Pharma price target raised to $275 from $256 at Morgan Stanley
9d ago
ASND
Premium
The Fly
Wedbush sees BioCryst, Ascendis as potential next targets after Crinetics deal
25d ago
ASND
BCRX
Premium
The Fly
Ascendis Pharma price target raised to $280 from $275 at RBC Capital
25d ago
ASND
Premium
Company Announcements
Ascendis Pharma Unveils Two-Year Pivotal Trial Data for TransCon CNP in Children With Achondroplasia
1M ago
6K
ASND
Premium
The Fly
Ascendis Pharma reports new radiographic data from Week 104 from ApproaCH Trial
1M ago
ASND
Premium
Company Announcements
Ascendis Pharma Closes Warrant Exercise Window, Expands Share Capital
1M ago
6K
ASND
Premium
The Fly
Ascendis Pharma added to multiple Russell U.S. Indexes
1M ago
ASND
Premium
Company Announcements
Ascendis Pharma Monetizes FDA Priority Review Voucher for $187.5 Million
1M ago
6K
ASND
Premium
Company Announcements
Ascendis Pharma Posts Strong 3.5-Year Phase 3 Data for TransCon PTH in Hypoparathyroidism
2M ago
6K
ASND
Premium
The Fly
Ascendis Pharma completes Phase 3 PaTHway Trial
2M ago
ASND
Premium
Company Announcements
Ascendis Pharma Reports Five-Year TransCon PTH Data Showing Sustained Benefits in Hypoparathyroidism
2M ago
6K
ASND
Premium
The Fly
Ascendis Pharma announces five-year data from PaTH Forward Trial
2M ago
ASND
Premium
Company Announcements
Ascendis Pharma Grants New Employee Warrants as Part of Updated Equity Incentive Plan
2M ago
6K
ASND
Premium
The Fly
Ascendis Pharma ‘oversold’ following ITC development, says Oppenheimer
2M ago
ASND
BMRN
Premium
Ratings
Analyst Reiterates Buy on Ascendis Pharma, Keeps $288 Price Target Amid ITC Uncertainty and Strong Yorvipath Rollout
2M ago
ASND
Premium
The Fly
StubHub, Jazz Pharmaceuticals upgraded: Wall Street’s top analyst calls
2M ago
AMT
BAP
Premium
The Fly
Ascendis Pharma initiated with a Buy at Citi
3M ago
ASND
Premium
The Fly
Ascendis Pharma price target raised to $329 from $324 at Evercore ISI
3M ago
ASND
Premium
Company Announcements
Ascendis Pharma Issues New Employee Warrants, Keeps Large Pool Available for Future Grants
3M ago
6K
ASND
Premium
The Fly
Ascendis Pharma price target raised to $345 from $342 at Barclays
3M ago
ASND
Premium
Company Announcements
Ascendis Pharma Earnings Call Highlights Growth Momentum
3M ago
ASND
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
